Maternus-Kliniken Aktiengesellschaft (MAK.DE)
EUR 1.49
(-2.61%)
EUR 1.49
(-2.61%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 111.79 Million EUR | -33.55% |
| 2022 | 168.25 Million EUR | 7.51% |
| 2021 | 156.49 Million EUR | -8.69% |
| 2020 | 171.39 Million EUR | 6.33% |
| 2019 | 161.19 Million EUR | 41.85% |
| 2018 | 113.64 Million EUR | 38.57% |
| 2017 | 82.01 Million EUR | 0.38% |
| 2016 | 81.7 Million EUR | -1.95% |
| 2015 | 83.33 Million EUR | -4.29% |
| 2014 | 87.06 Million EUR | -1.18% |
| 2013 | 88.1 Million EUR | 1.83% |
| 2012 | 86.52 Million EUR | 17301.19% |
| 2011 | -503 Thousand EUR | 22.02% |
| 2010 | -645 Thousand EUR | 56.51% |
| 2009 | -1.48 Million EUR | -102.11% |
| 2008 | 70.27 Million EUR | 52.92% |
| 2007 | 45.95 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 182.93 Million EUR | 0.0% |
| 2023 Q2 | 178.77 Million EUR | 5464.15% |
| 2023 Q3 | 105.68 Million EUR | -40.89% |
| 2023 FY | 111.79 Million EUR | -33.55% |
| 2023 Q4 | 105.68 Million EUR | 0.0% |
| 2023 Q1 | 3.21 Million EUR | -97.22% |
| 2022 Q1 | 13.6 Million EUR | -87.76% |
| 2022 Q4 | 115.74 Million EUR | 5.52% |
| 2022 Q3 | 109.69 Million EUR | -32.8% |
| 2022 Q2 | 163.22 Million EUR | 1099.45% |
| 2022 FY | 168.25 Million EUR | 7.51% |
| 2021 Q4 | 111.15 Million EUR | 6.75% |
| 2021 Q3 | 104.12 Million EUR | -39.48% |
| 2021 FY | 156.49 Million EUR | -8.69% |
| 2021 Q1 | 9.95 Million EUR | -92.17% |
| 2021 Q2 | 172.04 Million EUR | 1627.51% |
| 2020 Q3 | 120.19 Million EUR | -26.54% |
| 2020 Q1 | 721 Thousand EUR | -99.39% |
| 2020 Q2 | 163.62 Million EUR | 22594.04% |
| 2020 FY | 171.39 Million EUR | 6.33% |
| 2020 Q4 | 127.2 Million EUR | 5.83% |
| 2019 Q3 | 85.28 Million EUR | -46.23% |
| 2019 FY | 161.19 Million EUR | 41.85% |
| 2019 Q2 | 158.6 Million EUR | 4061.82% |
| 2019 Q1 | 3.81 Million EUR | -94.92% |
| 2019 Q4 | 118.75 Million EUR | 39.24% |
| 2018 Q4 | 75.07 Million EUR | 0.0% |
| 2018 Q3 | 75.07 Million EUR | -9.84% |
| 2018 Q2 | 83.26 Million EUR | 655.06% |
| 2018 FY | 113.64 Million EUR | 38.57% |
| 2018 Q1 | 11.02 Million EUR | -76.35% |
| 2017 Q3 | 46.62 Million EUR | -44.45% |
| 2017 Q4 | 46.62 Million EUR | 0.0% |
| 2017 Q2 | 83.94 Million EUR | 998.46% |
| 2017 Q1 | 7.64 Million EUR | -83.43% |
| 2017 FY | 82.01 Million EUR | 0.38% |
| 2016 Q4 | 46.1 Million EUR | 0.0% |
| 2016 FY | 81.7 Million EUR | -1.95% |
| 2016 Q3 | 46.1 Million EUR | -44.75% |
| 2016 Q2 | 83.45 Million EUR | 1322.98% |
| 2016 Q1 | 5.86 Million EUR | -92.96% |
| 2015 Q2 | 88.16 Million EUR | 3.23% |
| 2015 Q3 | 87.21 Million EUR | -1.08% |
| 2015 Q4 | 83.33 Million EUR | -4.46% |
| 2015 FY | 83.33 Million EUR | -4.29% |
| 2015 Q1 | 85.4 Million EUR | -1.91% |
| 2014 Q4 | 87.06 Million EUR | 2.84% |
| 2014 Q1 | 3.39 Million EUR | -96.15% |
| 2014 FY | 87.06 Million EUR | -1.18% |
| 2014 Q2 | 86.72 Million EUR | 2456.72% |
| 2014 Q3 | 84.66 Million EUR | -2.38% |
| 2013 Q3 | 83.5 Million EUR | -2.45% |
| 2013 FY | 88.1 Million EUR | 1.83% |
| 2013 Q2 | 85.6 Million EUR | -1.71% |
| 2013 Q1 | 87.09 Million EUR | 0.66% |
| 2013 Q4 | 88.1 Million EUR | 5.5% |
| 2012 Q2 | 36.49 Million EUR | 1353.52% |
| 2012 Q1 | 2.51 Million EUR | -96.98% |
| 2012 FY | 86.52 Million EUR | 17301.19% |
| 2012 Q4 | 86.52 Million EUR | 134.73% |
| 2012 Q3 | 36.86 Million EUR | 0.99% |
| 2011 FY | -503 Thousand EUR | 22.02% |
| 2011 Q3 | -704 Thousand EUR | -51.4% |
| 2011 Q2 | -465 Thousand EUR | 37.83% |
| 2011 Q4 | 83.14 Million EUR | 11910.51% |
| 2011 Q1 | -748 Thousand EUR | -15.97% |
| 2010 Q4 | -645 Thousand EUR | 0.0% |
| 2010 FY | -645 Thousand EUR | 56.51% |
| 2009 FY | -1.48 Million EUR | -102.11% |
| 2008 FY | 70.27 Million EUR | 52.92% |
| 2007 FY | 45.95 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 10.64 Billion EUR | 98.95% |
| Fresenius SE & Co. KGaA | 13.54 Billion EUR | 99.174% |
| LIMES Schlosskliniken AG | 1.57 Million EUR | -7015.693% |
| M1 Kliniken AG | -5.33 Million EUR | 2194.911% |
| MEDICLIN Aktiengesellschaft | 364.53 Million EUR | 69.331% |
| RHÖN-KLINIKUM Aktiengesellschaft | -56.2 Million EUR | 298.913% |
| VITA 34 AG | 4.15 Million EUR | -2588.122% |